LEVOFLOXACIN (LEVOFLOXACIN) — FDA Approval ANDA091436 (BAXTER HLTHCARE CORP)
LEVOFLOXACIN (LEVOFLOXACIN) — FDA Approval ANDA091436 (BAXTER HLTHCARE CORP) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LEVOFLOXACIN; Active ingredients: LEVOFLOXACIN; Application number: ANDA091436.
| Brand name | LEVOFLOXACIN |
|---|---|
| Active ingredients | LEVOFLOXACIN |
| Application number | ANDA091436 |
| Sponsor | BAXTER HLTHCARE CORP |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20130605 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →